Demonstrating the value of vaccines: global NITAG and HTA requirements

Now more than ever, HEOR and market access teams need to ensure they have a deep understanding of vaccine evaluation requirements to plan for success.

These slides are from our on-demand webinar How to demonstrate the value of vaccines: NITAG and HTA requirements where market access experts discuss:

  • which stakeholders are involved in vaccine evaluation, and global NITAG and HTA requirements 
  • the differences in vaccine modeling requirements among markets 
  • how to develop global value dossiers that meet the needs of NITAGs and HTA agencies. 

FREE Slides

Fill in your details to download your FREE Slides

Free download

We respect your privacy. Cookie policy.

Latest insights

How to demonstrate the value of vaccines ...

Recognizing Disability History Month in the workplace: 4 ...

Federal drug price regulations: is ‘Build Back ...